The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-10b'-(4-hydroxybut-2-en-2-yl)-4a',5'-dihydrospiro[cyclohexane-1,3'-naphtho[2,1-e][1,2,4]trioxin]-6'(10b'H)-one ID: ALA5206511
PubChem CID: 168295651
Max Phase: Preclinical
Molecular Formula: C20H24O5
Molecular Weight: 344.41
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C/C(=C/CO)C12OOC3(CCCCC3)OC1CC(=O)c1ccccc12
Standard InChI: InChI=1S/C20H24O5/c1-14(9-12-21)20-16-8-4-3-7-15(16)17(22)13-18(20)23-19(24-25-20)10-5-2-6-11-19/h3-4,7-9,18,21H,2,5-6,10-13H2,1H3/b14-9-
Standard InChI Key: HYTYVXOSYHLJQN-ZROIWOOFSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
22.2705 -18.1970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6750 -18.9027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4839 -18.9053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8945 -18.2038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4901 -17.4980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6750 -17.4938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6053 -17.4104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1789 -18.1103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5718 -18.8274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4202 -17.4270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8155 -18.1412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3903 -18.8443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7844 -19.5601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6053 -19.5791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3605 -20.2588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6349 -18.1539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0272 -18.8751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8433 -18.8958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.8810 -17.4760 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0587 -17.4535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4174 -17.3591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9952 -16.7772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7075 -16.9505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8124 -16.7772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2210 -16.0695 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
9 12 2 0
11 10 2 0
10 7 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 17 1 0
13 15 2 0
16 17 1 0
16 20 1 0
17 18 1 0
18 1 1 0
1 19 1 0
19 20 1 0
16 21 1 0
21 22 2 0
21 23 1 0
22 24 1 0
24 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 344.41Molecular Weight (Monoisotopic): 344.1624AlogP: 3.41#Rotatable Bonds: 2Polar Surface Area: 64.99Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.28CX LogD: 3.28Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.66Np Likeness Score: 1.35
References 1. Karnatak M, Hassam M, Vanangamudi M, Sharma S, Kumar Yadav D, Singh C, Puri SK, Rawat V, Prakash Verma V.. (2021) Novel naphthyl based 1,2,4-trioxanes: Synthesis and in vivo efficacy in the Plasmodium yoelii nigeriensis in Swiss mice., 51 [PMID:34547418 ] [10.1016/j.bmcl.2021.128372 ]